Autolus Therapeutics PLC AUTL 價格預測與預測



預測

AUTL 股票價格預測

Autolus Therapeutics PLC

$1.57

-2.48%

$-0.04

收盤價：May 08, 16:00:00 GMT-4

$1.63

3.82%

$0.05

盤後：May 08, 20:00:00 GMT-4

概觀預測收益股利財務狀況

關鍵數據

前收市價

$1.61

開盤價

$1.62

當日範圍

$1.55 - $1.63

52週區間

$1.15 - $2.7

交易量

1.1M

平均成交量

1.8M

股息收益率

每股盈餘 (TTM)

-1.80

市值

$433.8M

什麼是 AUTL？

Autolus Therapeutics Plc 是一家生物製藥公司，致力於基因療法的研發和商業化。公司專注於嵌合抗原受體（CAR）-T細胞療法。透過一系列專有且模組化的T細胞程式設計技術，公司正在開發具有靶向性、可控且高度活躍的T細胞治療產品候選藥物，旨在識別靶細胞、破壞其防禦機制並清除這些細胞。公司正在開發一系列產品候選藥物，用於治療血液系統惡性腫瘤、實體瘤和自身免疫疾病。其產品管線包括 obe-cel (FELIX)、obe-cel (ALLCAR19)、obe-cel (CAROUSEL)、AUTO1/22 (CARPALL)、AUTO4 (LibrA T1)、AUTO6 (MAGNETO)、AUTO5、AUTO8 (MCARTY) 和 AUTO9。AUTO4 和 AUTO5 是兩種程式化T細胞療法，用於治療外周T細胞淋巴瘤，靶向T細胞受體β鏈恆定區（TRBC）1和TRBC 2。

功能特性

Markets

News

使用條款隱私權政策

According to analyst forecasts, we anticipate notable price fluctuations for AUTL in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $8.72. The lowest target is $5.05 and the highest is $13.65. Empower your investment choices with our cutting-edge, data-driven analysis!

AUTL 股價預測摘要

AUTL 的頂級分析師評級

根據 17 位分析師對 AUTL 的股票評級，更新於 Sep 01, 2025

Strong Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for AUTL. Our analysts highlight strong fundamentals and favorable market sentiment, positioning AUTL for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: AUTL is a Strong Buy candidate.

AUTL stock price ended at $1.61 on 星期四, after dropping 5.29%

On the latest trading day May 07, 2026, the stock price of AUTL fell by 5.29%, dropping from $1.72 to $1.61. During the session, the stock saw a volatility of 10.83%, with prices oscillating between a daily low of $1.57 and a high of $1.74. On the latest trading day, the trading volume for AUTL decreased by 893.4K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 1.2M shares were traded, with a market value of approximately $428.4M.

AUTL 技術面訊號

技術面訊號摘要

買入訊號 3

中性訊號 2

賣出訊號 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

AUTL 目前顯示 3 個買入訊號與 2 個賣出訊號。該股票自 12:00 AM 以來一直處於下跌趨勢狀態，在此期間價格總共變動了 -5.29%。整體而言，技術指標顯示中期後市趨勢為 Buy。

AUTL 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為AUTL生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

기술 분석 지표는 AUTL에 어떻게 적용됩니까?



기술 분석에 따르면, Autolus Therapeutics PLC은 Buy의 종합 신호를 가지고 있습니다. Autolus Therapeutics PLC은 3개의 매수 신호, 2개의 중립 신호, 그리고 2개의 매도 신호를 가지고 있습니다.

AUTL의 피보나치 되돌림 수준은 무엇입니까?



Autolus Therapeutics PLC의 피보나치 되돌림 수준은 介於 23.6% 和 38.2% 之間입니다.

Autolus Therapeutics PLC의 RSI는 얼마입니까?



Autolus Therapeutics PLC의 현재 RSI는 58.65이며, 이는 中立 상태를 나타냅니다

다음 12개월 동안 Autolus Therapeutics PLC의 가격은 얼마입니까?



Autolus Therapeutics PLC AUTL의 다음 12개월 가격은 $8.72으로 추정됩니다.

Autolus Therapeutics PLC는 얼마나 높이 갈 것으로 예상됩니까?



월스트리트 분석가들에 따르면, Autolus Therapeutics PLC은 $13.65의 높은 예측치에 이를 것으로 예상됩니다.

Autolus Therapeutics PLC (AUTL) 股票價格預測

AUTL 股價走勢圖